Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 4; peer review: 2 approved, 2 approved with reservations]

Introduction Antimalarial therapeutic efficacy studies are routinely conducted in malaria-endemic countries to assess the effectiveness of antimalarial treatment strategies. Targeted amplicon sequencing (AmpSeq) uniquely identifies and quantifies genetically distinct parasites within an infection. I...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mainga Hamaluba, Juliana Wambua, Arjen M. Dondorp, Jennifer Musyoki, Caroline Ngetsa, Oksana Kharabora, Leonard Ndwiga, Zaydah de Laurent, Kevin Wamae, Kelvin Kimenyi, Gabriel Mwambingu, Peter Kalume, Philip Bejon, Jeffrey Bailey, Rob van der Pluijm, Lynette Ochola-Oyier, Jonathan Juliano, Victor Osoti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wellcome 2024-03-01
Colecção:	Wellcome Open Research
Assuntos:	Artemisinin-based combination therapy pfama1 Pfmdr1 artemisinin resistance antimalarial resistance targeted deep sequencing eng
Acesso em linha:	https://wellcomeopenresearch.org/articles/7-95/v4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!